Home · Compare

Mayukh Sukhatme vs Merdad V. Parsey M.D. Ph.D.

💰 How does your salary compare?

See how you rank against the world's top executives — free, instant, SEC-backed data

Mayukh Sukhatme earned $250.2M (15094%) more than Merdad V. Parsey M.D. Ph.D. in their most recent fiscal years on record.

Mayukh SukhatmeMerdad V. Parsey M.D. Ph.D.

CompanyRoivant SciencesGilead Sciences

TitlePresident and Chief Investment OfficerChief Medical Officer

IndustryHealthcareHealthcare

Fiscal YearFY2024FY2023

Total Pay$251.9M$1.7M

Base Salary$550,000—

Stock Awards$170.2M—

Bonus$81.1M—

Data Source: Figures are sourced from each executive's most recent DEF 14A proxy filing on record with the SEC. See something wrong? Report it.

← Back to database · Mayukh Sukhatme's full profile · Merdad V. Parsey M.D. Ph.D.'s full profile

ExecSalaries.com · Data sourced from SEC EDGAR DEF 14A proxy filings. · Home · About · Privacy Policy